Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. Welcome to the conference. My name is Naomi Kumagai, Japan Pharma Analyst, JPMorgan. It's my great pleasure to introduce Christophe Weber, President and CEO of Takeda. After his presentation, we're going to have a Q&A session at Borgia, across the hallway. With that, I'm going to pass it to Christophe.
Thank you. Thank you, and good afternoon. I hope you are still awake. It's a long day for everyone. What I can share with you today is that I am coming quite rare. But I'm coming to the JPMorgan conference with a big smile on my face because of what we have achieved at Takeda, and we are very proud of that. So this is what I want to share with you today. What is Takeda today? How we have been transforming the company over the years? At the same time, 12 months ago, during that week, we were closing the acquisition of Shire. We were celebrating our listing on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
